Wednesday's ETF Movers: IHI, PTF
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 08 2025
0mins
Should l Buy COHR?
Source: NASDAQ.COM
ETF Performance: The Invesco Dorsey Wright Technology Momentum ETF is down approximately 8.3% in Wednesday afternoon trading, underperforming other ETFs.
Weakest Components: Notable declines among its components include Aurora Innovation, which fell by about 9.2%, and Coherent, which decreased by about 4.3%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COHR
Wall Street analysts forecast COHR stock price to fall
13 Analyst Rating
9 Buy
4 Hold
0 Sell
Moderate Buy
Current: 280.810
Low
170.00
Averages
238.18
High
300.00
Current: 280.810
Low
170.00
Averages
238.18
High
300.00
About COHR
Coherent Corp., specializing in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. Its segments include Networking, Materials and Lasers. The Networking segment leverages its compound semiconductor technology platforms and knowledge of end-user applications for its key end markets to deliver differentiated components and subsystems. The Materials segment includes engineered materials and optoelectronic devices, such as those based on zinc selenide (ZnSe), zinc sulfide (ZnS), gallium arsenide (GaAs), indium phosphide (InP), gallium antimonide (GaSb), and silicon carbide (SiC). The Lasers segment's lasers and optics products serve industrial customers in semiconductor and display capital equipment, precision manufacturing, and aerospace & defense, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sen. Markwayne Mullin Resumes Stock Purchases, Focuses on Defense Stocks
- Stock Transaction Overview: Senator Mullin resumed stock purchases on February 4, 2026, acquiring shares in companies like Adobe, Citigroup, and Carpenter Technology, indicating his ongoing market engagement and investment confidence.
- Defense Stock Investment: His purchase of Carpenter Technology ($CRS), which manufactures alloys for defense contractors, has already seen a 22% increase in value, suggesting that his strategy in the defense sector could yield significant returns.
- Increased Market Scrutiny: Given his position on the Senate Armed Services Committee, Mullin's investment portfolio is under heightened scrutiny, particularly regarding potential conflicts of interest in his investments in defense and oil sectors.
- Historical Trade Review: Mullin previously bought six out of the seven Magnificent Seven stocks on December 29, 2025, reflecting his interest in large-cap tech stocks, although his past violations of the STOCK Act regarding transaction disclosures have raised concerns about his trading transparency.
See More
Van Den Berg Management Increases MarketAxess Holdings
- Share Acquisition: According to a SEC filing dated February 17, 2026, Van Den Berg Management I, Inc acquired an additional 16,382 shares of MarketAxess during Q4 2025, bringing its total position to $5.51 million, a $3.07 million increase, indicating strong confidence in the company.
- Asset Allocation: MarketAxess represents 1.26% of Van Den Berg's 13F reportable AUM, highlighting its significant role in the fund's portfolio and reflecting its strategic importance in the fixed income market.
- Market Performance: As of February 13, 2026, MarketAxess shares were priced at $179.36, down 4.8% over the past year, underperforming the S&P 500 by 16.6 percentage points, suggesting market caution regarding its future growth prospects.
- Industry Competition: As electronic trading expands, MarketAxess has become a leading platform in the U.S. corporate credit market; however, its future growth will depend on maintaining market share against competitors like Tradeweb and Bloomberg in the electronic credit trading space.
See More
Semtech Acquires HieFo for $34 Million to Enhance AI Infrastructure
- Acquisition Details: Semtech has acquired HieFo for $34 million in cash, aiming to enhance its data center portfolio and strengthen U.S. technology supply chains, particularly in the AI sector.
- Financial Impact: The acquisition of HieFo is expected to be accretive to adjusted diluted earnings per share within the first year, reflecting Semtech's confidence in its future profitability.
- Technology Integration: Semtech plans to combine HieFo's proven InP technology with its industry-leading TIAs and laser drivers to offer comprehensive solutions for next-generation optical platforms, thereby solidifying its leadership in high-bandwidth, low-power networking solutions.
- Market Sentiment: Despite Semtech's shares gaining over 153% in the past year, retail sentiment on Stocktwits remains neutral, indicating a cautious market reaction to the acquisition.
See More
Nvidia's $4 Billion Investment in Optical Technology Firms
- Significant Investment: Nvidia announced a $4 billion investment, allocating $2 billion each to Coherent and Lumentum, aimed at advancing innovation in optical technologies, thereby enhancing its competitive position in the photonics sector.
- Analyst Price Target Increases: Rosenblatt's Mike Genovese raised the price target for Lumentum from $580 to $900 and for Coherent from $300 to $375, indicating strong confidence in both companies and likely attracting more investor interest.
- Potential S&P 500 Inclusion: Boutique research firm Gordon Haskett believes that Lumentum and Coherent could be included in the S&P 500 this year, reflecting their leading positions among mid-cap peers and potentially increasing their market visibility and investment appeal.
- Positive Retail Sentiment: On Stocktwits, retail sentiment for COHR stock was in the 'extremely bullish' territory over the past 24 hours, while LITE stock was in the 'bullish' territory, indicating growing investor confidence in both stocks.
See More
Nvidia's $4 Billion Investment Boosts Photonics Stocks Outlook
- Massive Investment: Nvidia's announcement of a $4 billion investment in Lumentum and Coherent aims to bolster research and supply chains for its AI infrastructure, significantly enhancing both companies' competitiveness in the photonics sector.
- Positive Stock Reaction: Following the investment news, Coherent's stock surged over 15% and Lumentum's nearly 12%, although both experienced declines due to a broader market sell-off, indicating strong market interest in photonics stocks.
- Analysts Optimistic: JPMorgan analyst Samik Chatterjee believes this investment will enhance both companies' manufacturing capabilities in the U.S. and strengthen their partnership with Nvidia, which is expected to drive long-term growth.
- Market Potential Yet to Unfold: While Rosenblatt analyst Mike Genovese notes that the market for photonics technology may not scale significantly until 2029, Lumentum and Coherent have already surpassed $50 billion in market capitalization, reflecting strong investor confidence in the AI sector.
See More
Droplet Biosciences Partners with NVIDIA to Enhance Cancer Detection Efficiency
- Breakthrough in Cancer Detection: Droplet Biosciences collaborates with NVIDIA to analyze lymphatic fluid for residual cancer detection within 24 hours post-surgery, significantly reducing the time required compared to traditional blood monitoring, thereby enhancing clinical treatment timeliness and effectiveness.
- Increased Sensitivity: The company reports that post-surgical lymphatic fluid contains 130 times more tumor-derived DNA than blood plasma, nearly doubling the sensitivity for detecting rare residual cancer cells, providing clinicians with earlier opportunities for treatment adjustments.
- Optimized Computational Efficiency: By implementing NVIDIA Parabricks, Droplet has reduced sample alignment times from 36 hours to 3 hours and variant calling times from over 10 hours to about 1 hour, with an overall analysis timeline expected to shrink from 10 days to under 5 days, significantly improving operational efficiency.
- Cost-Effectiveness Analysis: Despite higher hourly GPU costs, the reduction in runtimes is projected to yield a 30% decrease in total computational expenses, providing stronger financial support for the company's ongoing development in cancer detection.
See More
Sen. Markwayne Mullin Resumes Stock Purchases, Focuses on Defense Stocks
- Stock Transaction Overview: Senator Mullin resumed stock purchases on February 4, 2026, acquiring shares in companies like Adobe, Citigroup, and Carpenter Technology, indicating his ongoing market engagement and investment confidence.
- Defense Stock Investment: His purchase of Carpenter Technology ($CRS), which manufactures alloys for defense contractors, has already seen a 22% increase in value, suggesting that his strategy in the defense sector could yield significant returns.
- Increased Market Scrutiny: Given his position on the Senate Armed Services Committee, Mullin's investment portfolio is under heightened scrutiny, particularly regarding potential conflicts of interest in his investments in defense and oil sectors.
- Historical Trade Review: Mullin previously bought six out of the seven Magnificent Seven stocks on December 29, 2025, reflecting his interest in large-cap tech stocks, although his past violations of the STOCK Act regarding transaction disclosures have raised concerns about his trading transparency.
See More
Van Den Berg Management Increases MarketAxess Holdings
- Share Acquisition: According to a SEC filing dated February 17, 2026, Van Den Berg Management I, Inc acquired an additional 16,382 shares of MarketAxess during Q4 2025, bringing its total position to $5.51 million, a $3.07 million increase, indicating strong confidence in the company.
- Asset Allocation: MarketAxess represents 1.26% of Van Den Berg's 13F reportable AUM, highlighting its significant role in the fund's portfolio and reflecting its strategic importance in the fixed income market.
- Market Performance: As of February 13, 2026, MarketAxess shares were priced at $179.36, down 4.8% over the past year, underperforming the S&P 500 by 16.6 percentage points, suggesting market caution regarding its future growth prospects.
- Industry Competition: As electronic trading expands, MarketAxess has become a leading platform in the U.S. corporate credit market; however, its future growth will depend on maintaining market share against competitors like Tradeweb and Bloomberg in the electronic credit trading space.
See More
Semtech Acquires HieFo for $34 Million to Enhance AI Infrastructure
- Acquisition Details: Semtech has acquired HieFo for $34 million in cash, aiming to enhance its data center portfolio and strengthen U.S. technology supply chains, particularly in the AI sector.
- Financial Impact: The acquisition of HieFo is expected to be accretive to adjusted diluted earnings per share within the first year, reflecting Semtech's confidence in its future profitability.
- Technology Integration: Semtech plans to combine HieFo's proven InP technology with its industry-leading TIAs and laser drivers to offer comprehensive solutions for next-generation optical platforms, thereby solidifying its leadership in high-bandwidth, low-power networking solutions.
- Market Sentiment: Despite Semtech's shares gaining over 153% in the past year, retail sentiment on Stocktwits remains neutral, indicating a cautious market reaction to the acquisition.
See More
Nvidia's $4 Billion Investment in Optical Technology Firms
- Significant Investment: Nvidia announced a $4 billion investment, allocating $2 billion each to Coherent and Lumentum, aimed at advancing innovation in optical technologies, thereby enhancing its competitive position in the photonics sector.
- Analyst Price Target Increases: Rosenblatt's Mike Genovese raised the price target for Lumentum from $580 to $900 and for Coherent from $300 to $375, indicating strong confidence in both companies and likely attracting more investor interest.
- Potential S&P 500 Inclusion: Boutique research firm Gordon Haskett believes that Lumentum and Coherent could be included in the S&P 500 this year, reflecting their leading positions among mid-cap peers and potentially increasing their market visibility and investment appeal.
- Positive Retail Sentiment: On Stocktwits, retail sentiment for COHR stock was in the 'extremely bullish' territory over the past 24 hours, while LITE stock was in the 'bullish' territory, indicating growing investor confidence in both stocks.
See More
Nvidia's $4 Billion Investment Boosts Photonics Stocks Outlook
- Massive Investment: Nvidia's announcement of a $4 billion investment in Lumentum and Coherent aims to bolster research and supply chains for its AI infrastructure, significantly enhancing both companies' competitiveness in the photonics sector.
- Positive Stock Reaction: Following the investment news, Coherent's stock surged over 15% and Lumentum's nearly 12%, although both experienced declines due to a broader market sell-off, indicating strong market interest in photonics stocks.
- Analysts Optimistic: JPMorgan analyst Samik Chatterjee believes this investment will enhance both companies' manufacturing capabilities in the U.S. and strengthen their partnership with Nvidia, which is expected to drive long-term growth.
- Market Potential Yet to Unfold: While Rosenblatt analyst Mike Genovese notes that the market for photonics technology may not scale significantly until 2029, Lumentum and Coherent have already surpassed $50 billion in market capitalization, reflecting strong investor confidence in the AI sector.
See More
Droplet Biosciences Partners with NVIDIA to Enhance Cancer Detection Efficiency
- Breakthrough in Cancer Detection: Droplet Biosciences collaborates with NVIDIA to analyze lymphatic fluid for residual cancer detection within 24 hours post-surgery, significantly reducing the time required compared to traditional blood monitoring, thereby enhancing clinical treatment timeliness and effectiveness.
- Increased Sensitivity: The company reports that post-surgical lymphatic fluid contains 130 times more tumor-derived DNA than blood plasma, nearly doubling the sensitivity for detecting rare residual cancer cells, providing clinicians with earlier opportunities for treatment adjustments.
- Optimized Computational Efficiency: By implementing NVIDIA Parabricks, Droplet has reduced sample alignment times from 36 hours to 3 hours and variant calling times from over 10 hours to about 1 hour, with an overall analysis timeline expected to shrink from 10 days to under 5 days, significantly improving operational efficiency.
- Cost-Effectiveness Analysis: Despite higher hourly GPU costs, the reduction in runtimes is projected to yield a 30% decrease in total computational expenses, providing stronger financial support for the company's ongoing development in cancer detection.
See More
